When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

In an advance for precision oncology, the largest published study to date on molecular residual disease (MRD) detection in stage 3 colon cancer has demonstrated the prognostic capabilities of Guardant ...

For all of the groundbreaking advancements in cancer treatment over the last decades, the first step for tackling almost all solid tumors is still surgery. | For all of the groundbreaking advancements ...

Skin manifestations are common in patients with SLE. A recent study reported increased site-specific recurrence of cutaneous ...

Because hazards vary over time, dynamic followup is preferred over one-size-fits-all syste ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...

New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may ...

Tamoxifen was approved by the FDA in 1977 to treat advanced breast cancer. In 1998, the Early Breast Cancer Trialists’ Cooperative Group published results showing that tamoxifen was effective in ...

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival ...

Patient With Chronic Myeloid Leukemia in Complete Cytogenetic Response: What Does It Mean, and What Does One Do Next? The results of the CROSS (Chemoradiotherapy for Oesophageal Cancer Followed by ...